Health Palatin Announces FDA Clearance of IND Application for the Treatment of Obesity with Co-Administration of Bremelanotide and Tirzepatide (GLP-1) Hey there! Big news from Palatin Technologies, Inc. They’ve got the green light from the FDA to kick off a Phase 2 clinical trial... adminMay 6, 2024